Frederik Joelving

Indian paper mill disbands WhatsApp community following investigation

An Indian paper mill featuring prominently in our recent investigation in Science and a companion piece on our website shut down its WhatsApp community six days after the stories ran, Retraction Watch has learned.

The company, called iTrilon, used the messaging platform to hawk authorship of “readymade” publications to scientists “struggling to write and publish papers in PubMed and Scopus-Indexed Journals.” It claimed to have connections at journals that allowed the mill to guarantee acceptance of most of its papers.

But on January 24, Sarath Ranganathan, iTrilon’s scientific director, deactivated the WhatsApp community he had been curating.

No data? No problem! Undisclosed tinkering in Excel behind economics paper

Last year, a new study on green innovations and patents in 27 countries left one reader slack-jawed. The findings were no surprise. What was baffling was how the authors, two professors of economics in Europe, had pulled off the research in the first place.

The reader, a PhD student in economics, was working with the same data described in the paper. He knew they were riddled with holes – sometimes big ones: For several countries, observations for some of the variables the study tracked were completely absent. The authors made no mention of how they dealt with this problem. On the contrary, they wrote they had “balanced panel data,” which in economic parlance means a dataset with no gaps.

“I was dumbstruck for a week,” said the student, who requested anonymity for fear of harming his career. (His identity is known to Retraction Watch.)

Journal pulls papers following Retraction Watch investigation

A journal quietly retracted two papers after a six-month Retraction Watch investigation linked them, and two of the journal’s editors, to the Indian paper mill iTrilon.

Based in Chennai, iTrilon hawks authorship of “readymade” publications to scientists “struggling to write and publish papers in PubMed and Scopus-Indexed Journals.” The company, whose website disappeared following our exposé in Science, claims to have connections at journals that allow it to guarantee acceptance of many of its papers.

The two retracted papers – “Evaluation of the neuroprotective activity of citral nanoemulsion on Alzheimer’s disease-type dementia in a preclinical model: The assessment of cognitive and neurobiochemical responses” and “Therapeutic effects of quercetin-loaded phytosome nanoparticles in a preclinical model of Parkinson’s disease: The modulation by antioxidant pathways and BDNF expression” – had both been put up for sale by iTrilon before they appeared last year in the non-indexed journal Life Neuroscience.

We published the matching ads last week in a companion piece to the Science article that linked a professor and dean at a university in Spain to several iTrilon papers. The dean, Dionisio Lorenzo Lorenzo Villegas of Universidad Fernando Pessoa-Canarias, in Las Palmas, acknowledged paying the paper mill, but said he thought the money was meant to cover article-processing charges. He has since taken down his LinkedIn profile.

Exclusive: Mayo, Florida profs among authors of article tied to Indian paper mill

Two assistant professors at universities in the United States are coauthors of a review that appears to have been advertised for sale by the Indian paper mill iTrilon, a Retraction Watch investigation has found.

One of the professors, Yuguang Liu of Mayo Clinic in Rochester, Minn., is also guest editor of the MDPI special issue in the journal Biosensors in which the review was published last year. The other professor, Ajeet Kaushik of Florida Polytechnic University, in Lakeland, sits on the editorial boards of Biosensors and several other titles from MDPI, Elsevier, Wiley, Springer Nature and other publishers.

An MDPI representative said Liu, who declined an interview request, had not been involved in editorial decisions regarding the paper. Meanwhile, Kaushik acknowledged his work on the article had sprung from a LinkedIn message from a researcher in India who, as we reported last week, has been offering co-authorship in return for help getting his articles published.

“This is sad,” Kaushik told us by email, adding that he had not seen “any red flags” when he agreed to collaborate on the review.

Wiley reopens plagiarism case about dead researcher’s work

Zulfiqar Habib, dean of computer science at COMSATS University Islamabad, in Pakistan, was appalled when he discovered part of a former PhD student’s dissertation had been published in a scientific journal.

After all, the former student, Kurshid Asghar, had been dead for more than a year by the time the manuscript was submitted to Security and Communication Networks, a Hindawi title. And Habib knew none of Asghar’s coauthors had contributed to the research, which Habib had supervised.

“It was both shocking and unbelievable,” he told Retraction Watch.

Exclusive: Paper-mill articles buoyed Spanish dean’s research output

Last year, a professor and dean at a university in Spain suddenly began publishing papers with a multitude of far-flung researchers. His coauthors, until then exclusively national, now came from places like India, China, Nepal, South Korea, Georgia, Austria, and the United States.

How these unlikely collaborations began is not entirely clear. But a six-month Retraction Watch investigation, part of which is published here as a companion piece to a longer article appearing today in Science, suggests an unsavory possibility: The dean, Dionisio Lorenzo Lorenzo Villegas of the faculty of health sciences at Universidad Fernando Pessoa-Canarias, in Las Palmas, bought his way onto the papers – something he partly admits.

At least six of the seven journal articles Lorenzo published last year had been previously advertised for sale by the Indian paper mill iTrilon. Based in Chennai, this underhand operation sells authorship of “readymade” publications to scientists “struggling to write and publish papers in PubMed and Scopus-Indexed Journals,” according to a WhatsApp message its scientific director, Sarath Ranganathan, sent to prospective clients last summer. Ranganathan also claimed to have connections at journals that allowed him, in many cases, to guarantee acceptance of the manuscripts he would send their way.

MDPI journal still publishing ‘cruel and unnecessary’ research despite extra checks, campaigners say

New editorial policies at an MDPI title accused of publishing “sadistic, cruel, and unnecessary” animal studies are missing the mark, according to the Physicians Committee for Responsible Medicine (PCRM), a U.S-based advocacy group.

The group is waging a campaign against MDPI’s Nutrients, which it says is “publishing egregious animal experiments that could have been ethically conducted in humans.” The journal’s guidelines require the “replacement of animals by alternatives wherever possible,” as a PCRM guest post for Retraction Watch pointed out last year.

A former reviewer for the journal, and one of the more than 1,100 signatories of a recent PCRM boycott letter, said she resigned from the post after realizing Nutrients published research that was “sadistic, cruel, and unnecessary,” according to a press release from November.

Email correspondence made public here for the first time shows Nutrients continues to reject the group’s concerns. In one message from 2022, it told PCRM that 21 papers flagged as problematic “contained ethics statements that are in accordance with the journal policies.”

Exclusive: Researcher outs Indian university’s publishing scam after it fails to pay him

On March 12, a senior administrator at a university in India sent a business proposal to a prolific economist in Ethiopia. If he joined the school’s stable of adjunct professors, the administrator promised, easy money could be made.

All the economist had to do was “add our affiliation for incentives in your papers,” explained Lakshmi Thangavelu, dean of international affairs at Saveetha Institute of Medical and Technical Sciences (SIMATS), in Chennai, in a written exchange.

“Surely I will do that. Not a big deal,” replied Mohd Asif Shah, an associate professor at Kebri Dehar University, in eastern Ethiopia.

But the deal turned sour. Although Shah listed SIMATS as an affiliation on at least two research papers he published this fall, in December he still hadn’t received any payments from the school, he complained. Then he turned to LinkedIn to share his frustration in a post that included screenshots of his conversation with Thangavelu, who is also a professor at Saveetha Dental College, part of SIMATS.

Psychology professor earns retractions after publishing with ‘repeat offenders’

A psychologist in Australia has earned a pair of retractions after publishing several papers with international coauthors suspected of authorship fraud, Retraction Watch has learned.

Kelly-Ann Allen, an associate professor at Monash University, in Clayton, and editor-in-chief of two psychology journals, declined to comment for this article.

The retraction notices, both in Frontiers journals, cite an investigation by the publisher confirming “a serious breach of our authorship policies and of publication ethics.”

‘I felt like a fraud’: A biologist goes public about a retraction

Retractions are the stuff of nightmares for most academics. But they aren’t necessarily a career obstacle, and sometimes may be the only way forward, according to Andrew P. Anderson, a postdoctoral researcher in the biology department of Reed College, in Portland, Ore. Last month, the journal Evolution pulled and replaced a study Anderson had conducted as a PhD student under Adam G. Jones at the University of Idaho, in Moscow. The study’s findings suggested sexual selection shaped the responsiveness of the human genome to male sex hormones. Below is a lightly edited Q&A we did with Anderson about his experience.

Retraction Watch (RW): In the summer of 2022, shortly after your paper was first published, you realized it contained a significant error. What happened?

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: